3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
64
Neoplasm Metastasis
14
Brain Neoplasms
10
Neoplasms
9
Endometrial Neoplasms
8
Prostatic Neoplasms
7
Glioblastoma
7
Ovarian Neoplasms
6
Triple Negative Breast Neoplasms
5
Glioma
5
Sarcoma
3
Recurrence
3
Neoplasms by Site
3
Meningioma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Diseases
3
Unilateral Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Osteosarcoma
2
Liposarcoma
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
enzalutamide
4
Docetaxel
3
abiraterone
2
Prednisone
2
Abiraterone Acetate
2
relugolix
1
pembrolizumab
1
olaparib
1
lenvatinib
1
inavolisib
1
belzutifan
1
apalutamide
1
PF06821497
1
Methylprednisolone
1
Lutetium-177
1
Lutetium
1
Gonadotropin-Releasing Hormone
1
Etoposide
1
Dexamethasone
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Metastatic Castration-Resistant Prostate Cancer
×
abemaciclib
×
1 year
×
Clear all
No trials found.